In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer

K. Sugimachi, Y. Maehara, T. Kusumoto, T. Okamura, D. Korenaga, S. Kohnoe, H. Baba, H. Anai

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The effect of PSK, a protein-bound polysaccharide and an immunomodulator, on lymphocytes was examined in vitro for 36 patients with gastric cancer and 26 with colorectal cancer. Cultured lymphocytes with PSK at 100 μg/ml increased the level of DNA synthesis, as determined by the 3H-thymidine uptake, from 0.9 to 3.0 fold, compared to the PSK non-treated cells. The increase was 1.36±0.46 fold for the gastric cancer cases and 1.37+0.45 fold for the colorectal cancer cases, and these levels were significantly the finding of 1.93+0.55 fold for a control group consisting of 15 healthy volunteers (P<0.01). When the 1.3 fold increase of 3H-thymidine uptake was defined as the PSK-reactive group, 52.8% (19/36) for colorectal cancer were found in the PSK-reactive group. The PSK-reactive group demonstrated no relation to the age and sex of the patients, tissue differentiation type or tumor advancement. Our findings thus show that the in vitro activation of lymphocytes by PSK can help identify the candidates with either gastric or colorectal cancer who are the best suited to undergo immunotherapy including treatment with PSK.

Original languageEnglish
Pages (from-to)2175-2179
Number of pages5
JournalAnticancer research
Volume15
Issue number5 B
Publication statusPublished - Dec 1 1995

Fingerprint

Gastrointestinal Neoplasms
Polysaccharides
Lymphocytes
Colorectal Neoplasms
Proteins
Stomach Neoplasms
Thymidine
krestin
In Vitro Techniques
Immunologic Factors
Lymphocyte Activation
Immunotherapy
Healthy Volunteers
Control Groups
DNA

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Sugimachi, K., Maehara, Y., Kusumoto, T., Okamura, T., Korenaga, D., Kohnoe, S., ... Anai, H. (1995). In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer. Anticancer research, 15(5 B), 2175-2179.

In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer. / Sugimachi, K.; Maehara, Y.; Kusumoto, T.; Okamura, T.; Korenaga, D.; Kohnoe, S.; Baba, H.; Anai, H.

In: Anticancer research, Vol. 15, No. 5 B, 01.12.1995, p. 2175-2179.

Research output: Contribution to journalArticle

Sugimachi, K, Maehara, Y, Kusumoto, T, Okamura, T, Korenaga, D, Kohnoe, S, Baba, H & Anai, H 1995, 'In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer', Anticancer research, vol. 15, no. 5 B, pp. 2175-2179.
Sugimachi K, Maehara Y, Kusumoto T, Okamura T, Korenaga D, Kohnoe S et al. In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer. Anticancer research. 1995 Dec 1;15(5 B):2175-2179.
Sugimachi, K. ; Maehara, Y. ; Kusumoto, T. ; Okamura, T. ; Korenaga, D. ; Kohnoe, S. ; Baba, H. ; Anai, H. / In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer. In: Anticancer research. 1995 ; Vol. 15, No. 5 B. pp. 2175-2179.
@article{dfbed978f42e487284add2f0a5d1c0f7,
title = "In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer",
abstract = "The effect of PSK, a protein-bound polysaccharide and an immunomodulator, on lymphocytes was examined in vitro for 36 patients with gastric cancer and 26 with colorectal cancer. Cultured lymphocytes with PSK at 100 μg/ml increased the level of DNA synthesis, as determined by the 3H-thymidine uptake, from 0.9 to 3.0 fold, compared to the PSK non-treated cells. The increase was 1.36±0.46 fold for the gastric cancer cases and 1.37+0.45 fold for the colorectal cancer cases, and these levels were significantly the finding of 1.93+0.55 fold for a control group consisting of 15 healthy volunteers (P<0.01). When the 1.3 fold increase of 3H-thymidine uptake was defined as the PSK-reactive group, 52.8{\%} (19/36) for colorectal cancer were found in the PSK-reactive group. The PSK-reactive group demonstrated no relation to the age and sex of the patients, tissue differentiation type or tumor advancement. Our findings thus show that the in vitro activation of lymphocytes by PSK can help identify the candidates with either gastric or colorectal cancer who are the best suited to undergo immunotherapy including treatment with PSK.",
author = "K. Sugimachi and Y. Maehara and T. Kusumoto and T. Okamura and D. Korenaga and S. Kohnoe and H. Baba and H. Anai",
year = "1995",
month = "12",
day = "1",
language = "English",
volume = "15",
pages = "2175--2179",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5 B",

}

TY - JOUR

T1 - In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer

AU - Sugimachi, K.

AU - Maehara, Y.

AU - Kusumoto, T.

AU - Okamura, T.

AU - Korenaga, D.

AU - Kohnoe, S.

AU - Baba, H.

AU - Anai, H.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - The effect of PSK, a protein-bound polysaccharide and an immunomodulator, on lymphocytes was examined in vitro for 36 patients with gastric cancer and 26 with colorectal cancer. Cultured lymphocytes with PSK at 100 μg/ml increased the level of DNA synthesis, as determined by the 3H-thymidine uptake, from 0.9 to 3.0 fold, compared to the PSK non-treated cells. The increase was 1.36±0.46 fold for the gastric cancer cases and 1.37+0.45 fold for the colorectal cancer cases, and these levels were significantly the finding of 1.93+0.55 fold for a control group consisting of 15 healthy volunteers (P<0.01). When the 1.3 fold increase of 3H-thymidine uptake was defined as the PSK-reactive group, 52.8% (19/36) for colorectal cancer were found in the PSK-reactive group. The PSK-reactive group demonstrated no relation to the age and sex of the patients, tissue differentiation type or tumor advancement. Our findings thus show that the in vitro activation of lymphocytes by PSK can help identify the candidates with either gastric or colorectal cancer who are the best suited to undergo immunotherapy including treatment with PSK.

AB - The effect of PSK, a protein-bound polysaccharide and an immunomodulator, on lymphocytes was examined in vitro for 36 patients with gastric cancer and 26 with colorectal cancer. Cultured lymphocytes with PSK at 100 μg/ml increased the level of DNA synthesis, as determined by the 3H-thymidine uptake, from 0.9 to 3.0 fold, compared to the PSK non-treated cells. The increase was 1.36±0.46 fold for the gastric cancer cases and 1.37+0.45 fold for the colorectal cancer cases, and these levels were significantly the finding of 1.93+0.55 fold for a control group consisting of 15 healthy volunteers (P<0.01). When the 1.3 fold increase of 3H-thymidine uptake was defined as the PSK-reactive group, 52.8% (19/36) for colorectal cancer were found in the PSK-reactive group. The PSK-reactive group demonstrated no relation to the age and sex of the patients, tissue differentiation type or tumor advancement. Our findings thus show that the in vitro activation of lymphocytes by PSK can help identify the candidates with either gastric or colorectal cancer who are the best suited to undergo immunotherapy including treatment with PSK.

UR - http://www.scopus.com/inward/record.url?scp=0029566263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029566263&partnerID=8YFLogxK

M3 - Article

C2 - 8572620

AN - SCOPUS:0029566263

VL - 15

SP - 2175

EP - 2179

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5 B

ER -